94 related articles for article (PubMed ID: 11739439)
1. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.
Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK
J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439
[TBL] [Abstract][Full Text] [Related]
2. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
3. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
[TBL] [Abstract][Full Text] [Related]
5. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
[TBL] [Abstract][Full Text] [Related]
6. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions.
Wild A; Langer P; Celik I; Chaloupka B; Bartsch DK
Eur J Endocrinol; 2002 Oct; 147(4):507-13. PubMed ID: 12370114
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J
Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598
[TBL] [Abstract][Full Text] [Related]
10. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
[TBL] [Abstract][Full Text] [Related]
11. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O
Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
[TBL] [Abstract][Full Text] [Related]
15. Absence of mutations on the SNF5 gene in hematological neoplasms with chromosome 22 abnormalities.
Mori N; Inoue K; Okada M; Motoji T
Acta Haematol; 2011; 126(2):69-75. PubMed ID: 21494030
[TBL] [Abstract][Full Text] [Related]
16. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
17. INI1 mutations in meningiomas at a potential hotspot in exon 9.
Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A
Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of INI1 in sporadic human brain tumors.
Weber M; Stockhammer F; Schmitz U; von Deimling A
Acta Neuropathol; 2001 May; 101(5):479-82. PubMed ID: 11484819
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.
Dietrich WF; Radany EH; Smith JS; Bishop JM; Hanahan D; Lander ES
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9451-5. PubMed ID: 7937788
[TBL] [Abstract][Full Text] [Related]
20. Absence of hSNF5/INI1 mutation in human lung cancer.
Manda R; Kohno T; Hamada K; Takenoshita S; Kuwano H; Yokota J
Cancer Lett; 2000 May; 153(1-2):57-61. PubMed ID: 10779630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]